TotalMarketCap

SL Science

SLBTNasdaq TaiwanHealth CareBiotechnology: Biological Products (No Diagnostic Substances)

Market cap

$504.684 M

$0.90 -18.92%

Close of 6 Nov 2026

As of 6 Nov 2026, SL Science (SLBT) has a market capitalization of $504.7M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

1

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 163 →
  1. #63Entera BioENTX$521.8M
  2. #64SurrozenSRZN$517.4M
  3. #65SL ScienceSLBT$504.7M
  4. #66RegenxbioRGNX$487.2M
  5. #67Electra TherapeuticsETRA$449.4M

What if SL Science were worth as much as…

Open the what-if tool →

Gold $28.2T

$50,354.67

Per share 55,950× higher

Bitcoin $1.53T

$2,724.60

Per share 3,027× higher

Apple $5.02T

$8,944.62

Per share 9,938× higher

Or at a round number

$1.00B$2.00B$5.00B$10.0B

Where these numbers come from

Share counts and financials for SL Science are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.